Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: To describe the bioactivity of circulating androgens during pubertal transition as determined by an in vitro bioassay assessing androgen receptor (AR) activation, and to compare these findings with circulating concentrations of total testosterone (total T) measured by LC-MS/MS.
Methods: This longitudinal study included ten healthy boys from the Copenhagen Puberty Study II conducted from 2006 to 2011.
Main Outcome Measure(s): Androgen bioactivity and serum concentrations of total T were measured by an in vitro bioassay and LC-MS/MS with limits of detection of 0.3 and 0.01 nmol/L, respectively. The serum concentration of free testosterone (free T) was calculated using the Vermeulen equation. Pubertal onset was defined as testicular enlargement ≥ 4 mL, assessed by palpation.
Results: Androgen bioactivity was unmeasurable before puberty but measurable in nine of ten boys 0.8-1.7 years after pubertal onset. Total T and free T were measurable prepubertally in all boys and increased in two before pubertal onset. Androgen bioactivity correlated strongly with total T (r = 0.93, p < 0.001) and free T (r = 0.93, p < 0.001). ROC accuracies were 77% for androgen bioactivity, 93% for total T, and 95% for free T.
Conclusion: Androgen bioactivity was undetectable before pubertal onset but measurable after in most boys, reflecting both the bioassay's lower sensitivity and potential physiological changes in androgen bioactivity during early puberty. Further studies are needed to clarify these observations.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12223714 | PMC |
| http://dx.doi.org/10.1111/cen.15249 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A novel cell-free regenerative therapy for hair loss: human fetal cartilage progenitor cell secretome.
Biomaterials
February 2026
Department of Orthopedic Surgery, School of Medicine, Ajou University, Suwon, Republic of Korea; Institute of Regenerative Medicine, Wake Forest University, NC, USA; Advanced Translational Engineering & Medical Science, Seoul, Republic of Korea. Electronic address:
Hair loss, particularly androgenic alopecia, is driven by testosterone-induced apoptosis and impaired dermal papilla (DP) cell function, disrupting epithelial-mesenchymal interactions and hindering hair follicle regeneration. Current non-surgical treatments, such as minoxidil and finasteride, provide limited and temporary benefits. Here, we report the development of a novel, cell-free regenerative therapy using the secretome of human fetal cartilage progenitor cells (ShFCPC), enriched with extracellular matrix (ECM) proteins and bioactive factors critical for tissue remodeling and cell survival.
View Article and Find Full Text PDFAnti-Hair Loss Potential of Perilla Seed Extracts: In Vitro Molecular Insights from Supercritical Fluid Extraction.
Foods
July 2025
Research Group in Innovative Technologies for Sustainable Food (ALISOST), Department of Preventive Medicine and Public Health, Food Science, Toxicology and Forensic Medicine, Faculty of Pharmacy, Universitat de València, Avenida Vicent Andrés Estellés s/n, 46100 Burjassot, Spain.
Perilla seed has long been recognized in traditional diets for its health-promoting properties, but its potential role in hair loss prevention remains underexplored. This study compared three extraction methods-maceration (MAC), screw pressing (SC), and supercritical fluid extraction (SFE)-to determine their efficiency in recovering bioactive compounds and their effects on androgenetic alopecia (AGA)-related pathways. The SFE extract contained the highest levels of polyunsaturated fatty acids and tocopherols, while MAC uniquely recovered a broader range of polyphenols.
View Article and Find Full Text PDFNatural Oil and Polycystic Ovary Syndrome: A Comprehensive Review of Therapeutic Benefits.
Curr Top Med Chem
August 2025
Faculty of Pharmaceutical Science, Assam Down Town University, Sankar Madhab Path, Gandhi Nagar, Panikhaiti, Guwahati, Assam, India, PIN - 781026.
Introduction: Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder affecting 70-75% of women. This condition is frequently linked with large and dysfunctional ovaries, high levels of androgens, and insulin resistance. A variety of conventional treatments, including metformin, oral contraceptives, and anti-androgen agents, have been used to treat PCOS and its complications, but they have been linked to several negative side effects, including hyperkalemia, weight gain, cardiovascular and hepatic toxicity, vitamin B12 and folic acid deficiency.
View Article and Find Full Text PDFA SARM a Day Keeps the Weakness Away: A Computational Approach for Selective Androgen Receptor Modulators (SARMs) and Their Interactions with Androgen Receptor and 5‑Alpha Reductase Proteins.
ACS Omega
July 2025
Laboratory of Pharmacological and Toxicological Evaluations Applied to Bioactive Molecules - LaftamBio - Federal University of Pampa, Itaqui, CEP 97650-000, RS, Brazil.
This study examines the molecular interactions of selective androgen receptor modulators (SARMs) with the androgen receptor (AR) and 5-alpha reductase II (5αRII), highlighting their potential as dual-action pharmacological candidates, using molecular modeling techniques to evaluate their primary interactions, providing valuable insights into conformational stability and ligand-induced changes and enabling rational analysis of SARMs with optimized pharmacological profiles. Employing molecular docking, density functional theory (DFT), and molecular dynamics simulations, we analyzed the binding affinities and conformational stability. Between all eight SARMs tested, 4'-[(2,3)-2-ethyl-3-hydroxy-5-oxopyrrolidin-1-yl]-2'-(trifluoromethyl)-benzonitrile (Sarm2f) demonstrated exceptional stability and binding affinity with critical interactions at key AR residues such as Asn705, Glu711, Arg752, and Thr877.
View Article and Find Full Text PDFFucoidan treatment reverses hair loss and inhibits inflammatory responses in a mouse model of androgenetic alopecia.
Int J Biol Macromol
September 2025
College of Chemical Engineering, Huaqiao University, Xiamen, Fujian 361021, China; Xiamen Engineering and Technological Research Center for Comprehensive Utilization of Marine Biological Resources, Xiamen 361021, China.
Androgenetic alopecia (AGA), a prevalent form of hair loss, is typically treated with minoxidil and finasteride, but their efficacy and safety are somewhat constrained. Previous studies have shown that fucoidan can regulate VEGF and Wnt signaling pathways, which are critical for hair growth. Based on bioactivity screening protocols for natural product, we hypothesized that fucoidan may exert beneficial effects on AGA, potentially through modulation of the Wnt pathway and other molecular mechanisms.
View Article and Find Full Text PDF